Delivery Order SPE2DB22D3501-SPE2DB23FWM66

Award Date 7/21/23
Potential Completion Date 8/11/23
Potential Value $655
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $726 delivery order to Amerisourcebergen Drug Corporation for 4561465393 ENVARSUS XR 1 MG tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 100 tablets to a facility in Conshohocken, Pennsylvania by August 1, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, the Defense Logistics Agency utilizes contracts such as Amerisourcebergen's...
The Defense Logistics Agency awarded a $996 delivery order to Amerisourcebergen Drug Corporation for 4561453171 ENVARSUS XR 0.75 MG tablets. Under the firm fixed price contract, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania by July 31, 2023. As a top pharmaceutical supplier, Amerisourcebergen frequently supports the Defense Logistics Agency's mission to provide medical supplies to the U.S. Department of Defense. No subcontractors or set aside...
The Defense Logistics Agency awarded a $637 delivery order to Amerisourcebergen Drug Corporation for 4562205758 ENVARSUS XR 1 MG tablets. Under this firm fixed price order, Amerisourcebergen will deliver 100 tablets to a facility in Conshohocken, Pennsylvania by October 10th to support the Defense Logistics Agency's medical supply needs. As a top supplier on the Agency's Pharmaceutical Prime Vendor contract, Amerisourcebergen will fulfill this requirement from its corporate headquarters...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $498 to Amerisourcebergen Drug Corporation to supply 4561968977 ENVARSUS XR 0.75 MG tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania, with performance required between August 28 and September 19, 2023. No set aside designation or subcontractors were indicated. This order is consistent with DLA's mission to provide logistics...
The Defense Logistics Agency awarded a $327,660 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561853549 ENVARSUS XR 1 MG tablets. The prime contractor, Amerisourcebergen Drug Corporation, will deliver 30 tablets from its Conshohocken, Pennsylvania facility in support of the Defense Logistics Agency's pharmaceutical supply needs. No subcontractors or set aside designations were specified. The delivery order runs from August 17, 2023 through...
The Defense Logistics Agency awarded a $982 delivery order to Amerisourcebergen Drug Corporation for 4561786742 ENVARSUS XR 1 MG tablets. Under this firm fixed price order, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania by September 1st to support the DLA's medical supply needs. As a top pharmaceutical supplier, Amerisourcebergen frequently fulfills delivery orders under the DLA's Prime Vendor program, which consolidates medical material procurement for...
The Defense Logistics Agency awarded a $363,130 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561682479 ENVARSUS XR 1 MG tablets. The prime contractor will deliver 100 count bottles of the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania by August 23, 2023 in support of DLA programs. Amerisourcebergen will perform under this delivery order utilizing its own resources, as no subcontractors were identified. The Defense Logistics Agency...
The Defense Logistics Agency awarded a $1,000.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561543482 ENVARSUS XR 1 MG tablets. As the prime contractor, Amerisourcebergen will deliver 100 count bottles of the specified pharmaceutical product for use by the Department of Defense from its facility in Conshohocken, Pennsylvania. Performance is required between July 19th and August 9th, 2023. The ordering agency, DLA, manages the procurement of medical...
The Defense Logistics Agency Troop Support Medical awarded a $363,130 delivery order to Amerisourcebergen Drug Corporation for 4561807008 ENVARSUS XR 1 MG tablets. The firm fixed price order is for 100 tablets to be delivered to a location in Conshohocken, Pennsylvania between August 14 and September 5, 2023. Amerisourcebergen will fulfill the order as the prime contractor. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $873.76 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4561971176 ENVARSUS XR 1 MG TABLET 30S to the agency. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, between August 28 and September 19, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order supports the Defense Logistics...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB23FWM66
    Delivery Order

The Defense Logistics Agency awarded a $655 delivery order to Amerisourcebergen Drug Corporation for 4561568335 ENVARSUS XR 1 MG tablets. The firm fixed price order is for 30 tablets to be delivered to a facility in Conshohocken, Pennsylvania between July 21 and August 11, 2023. As a top supplier on the DLA's Pharmaceutical Prime Vendor contract vehicle, Amerisourcebergen will fulfill this requirement for a common brand name drug to support the Department of Defense's healthcare programs. No subcontractors or set aside designations were identified.

Generated 12/17/23, 5:42 AM